World's Best Scientists 2026 revealed!
Yutaka Nishiwaki

Yutaka Nishiwaki

D-Index & Metrics

Medicine

D-Index
84
Citations
36784
World Ranking
14868
National Ranking
454

Yutaka Nishiwaki publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Yutaka Nishiwaki sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 390 publications — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Yutaka Nishiwaki D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Yutaka Nishiwaki sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 84 D-Index — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Yutaka Nishiwaki is affiliated with Tokyo Medical University in Japan. Their research primarily spans the field of Medicine, with a focus across several subfields including Pulmonary and Respiratory Medicine, Epidemiology, Oncology, Cardiology and Cardiovascular Medicine, and Surgery.

The scientist's main research topics encompass diverse areas related to heart and lung diseases, including:

  • Congenital Heart Disease Studies
  • Aortic Disease and Treatment Approaches
  • Lung Cancer Treatments and Mutations
  • Colorectal Cancer Treatments and Studies
  • Gastric Cancer Management and Outcomes
  • Cardiac Valve Diseases and Treatments
  • Cardiac Structural Anomalies and Repair

Yutaka Nishiwaki has contributed to multiple recent scientific papers, covering clinical trials, retrospective cohort studies, and methodological research. These publications include:

  • "Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer," 2023, Journal of Clinical Oncology
  • "Reinterventions and medical costs after tetralogy of Fallot repair: a retrospective cohort study using health insurance claims in Japan," 2025, General Thoracic and Cardiovascular Surgery
  • "Novel transparent patch as an adjunct to adult pulmonary valve replacement," 2025, General Thoracic and Cardiovascular Surgery
  • "Maximum likelihood estimation of mean functions for Gaussian processes under small noise asymptotics," 2025, arXiv (Cornell University)

The scientist frequently publishes in the following venues:

  • General Thoracic and Cardiovascular Surgery
  • Journal of Clinical Oncology
  • arXiv (Cornell University)

Yutaka Nishiwaki has collaborated with several coauthors including:

  • Masahiro Fukuoka
  • Seiji Yano
  • Giuseppe Giaccone
  • Tomohide Tamura
  • Kazuhiko Nakagawa

Best Publications

  • Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma

    Tony S. Mok;Yi Long Wu;Sumitra Thongprasert;Chih Hsin Yang

  • Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer

    Masahiro Fukuoka;Seiji Yano;Giuseppe Giaccone;Tomohide Tamura

  • Irinotecan plus Cisplatin Compared with Etoposide plus Cisplatin for Extensive Small-Cell Lung Cancer

    Kazumasa Noda;Yutaka Nishiwaki;Masaaki Kawahara;Shunichi Negoro

  • Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan

    Y Ohe;Y Ohashi;K Kubota;T Tamura

  • Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Cisplatin and Etoposide for Limited-Stage Small-Cell Lung Cancer: Results of the Japan Clinical Oncology Group Study 9104

    Minoru Takada;Masahiro Fukuoka;Masaaki Kawahara;Takahiko Sugiura

  • A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer.

    M Fukuoka;H Niitani;A Suzuki;M Motomiya

  • Randomized Trial of Cyclophosphamide, Doxorubicin, and Vincristine Versus Cisplatin and Etoposide Versus Alternation of These Regimens in Small-Cell Lung Cancer

    Masahiro Fukuoka;Kiyoyuki Furuse;Nagahiro Saijo;Yutaka Nishiwaki

  • Video-assisted thoracoscopic surgery for small indeterminate pulmonary nodules: indications for preoperative marking.

    Kenji Suzuki;Kanji Nagai;Junji Yoshida;Hironobu Ohmatsu

  • Phase III Study, V-15-32, of Gefitinib Versus Docetaxel in Previously Treated Japanese Patients With Non–Small-Cell Lung Cancer

    Riichiroh Maruyama;Yutaka Nishiwaki;Tomohide Tamura;Nobuyuki Yamamoto

  • Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.

    Osamu Kawai;Genichiro Ishii;Kaoru Kubota;Yukinori Murata

  • Interstitial lung disease in Japanese patients with lung cancer: a cohort and nested case-control study.

    Shoji Kudoh;Harubumi Kato;Yutaka Nishiwaki;Masahiro Fukuoka

  • Prognostic implications of fibrotic focus (scar) in small peripheral lung cancers.

    Y Shimosato;A Suzuki;T Hashimoto;Y Nishiwaki

  • Prognostic significance of the size of central fibrosis in peripheral adenocarcinoma of the lung.

    Kenji Suzuki;Tomoyuki Yokose;Junji Yoshida;Mitsuyo Nishimura

  • Breast cancer resistance protein impacts clinical outcome in platinum-based chemotherapy for advanced non-small cell lung cancer.

    Kiyotaka Yoh;Genichiro Ishii;Tomoyuki Yokose;Yuji Minegishi

  • Phase III Randomized Trial of Docetaxel Plus Cisplatin Versus Vindesine Plus Cisplatin in Patients With Stage IV Non-Small-Cell Lung Cancer: The Japanese Taxotere Lung Cancer Study Group

    Kaoru Kubota;Koshiro Watanabe;Hideo Kunitoh;Kazumasa Noda

  • Increased cyclooxygenase 2 (COX-2) expression occurs frequently in precursor lesions of human adenocarcinoma of the lung.

    Yukio Hosomi;Tomoyuki Yokose;Yuko Hirose;Ryu Nakajima

  • Limited resection trial for pulmonary ground-glass opacity nodules: fifty-case experience.

    Junji Yoshida;Kanji Nagai;Tomoyuki Yokose;Mitsuyo Nishimura

  • Visceral pleural invasion is an invasive and aggressive indicator of non-small cell lung cancer.

    Kimihiro Shimizu;Junji Yoshida;Kanji Nagai;Mitsuyo Nishimura

  • Progression of focal pure ground-glass opacity detected by low-dose helical computed tomography screening for lung cancer.

    Ryutaro Kakinuma;Hironobu Ohmatsu;Masahiro Kaneko;Masahiko Kusumoto

  • First-Line Single Agent Treatment With Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer: A Phase II Study

    Seiji Niho;Kaoru Kubota;Koichi Goto;Kiyotaka Yoh

Frequent Co-Authors

Kanji Nagai
Kanji Nagai Kitasato University
Nagahiro Saijo
Nagahiro Saijo AstraZeneca (United Kingdom)
Yuichiro Ohe
Yuichiro Ohe National Cancer Centre
Tomohide Tamura
Tomohide Tamura St. Luke's International Hospital
Masahiro Fukuoka
Masahiro Fukuoka Kindai University
Atsushi Ochiai
Atsushi Ochiai University of Tokyo
Kenji Suzuki
Kenji Suzuki Juntendo University
Kazuhiko Nakagawa
Kazuhiko Nakagawa Kindai University
Yosuke Uchitomi
Yosuke Uchitomi National Cancer Research Institute, UK
Tatsuo Akechi
Tatsuo Akechi Nagoya City University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in studying Medicine in the USA, there are several alternative online degrees and career pathways in the healthcare sector worth exploring. For those drawn to the management side of healthcare, earning a healthcare administration online degree can prepare you for leadership roles in hospitals, clinics, and healthcare organizations. This path offers flexibility and strong job prospects without the need for a medical license.

Aspiring nurses may consider various bridge programs to advance their roles. Options like rn to np programs help registered nurses move efficiently towards becoming nurse practitioners—unlocking higher earning potential and professional autonomy.

For those with an interest in nutrition and wellness, an online nutritionist degree can pave the way for careers in clinical settings, wellness centers, or private practice.

If your goal is executive management in healthcare, the best online mha programs provide robust training for top leadership roles and policy positions.

Best Scientists Citing Yutaka Nishiwaki

Trending Scientists

Recently Published Articles